TPC

Takeda Pharmaceutical Company Portfolio holdings

AUM $19.6M
1-Year Est. Return 13.61%
This Quarter Est. Return
1 Year Est. Return
-13.61%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.6M
AUM Growth
+$3.36M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
11
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1 +$9

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLVX
1
DELISTED
HilleVax
HLVX
$13.4M 68.43%
6,724,000
OVID icon
2
Ovid Therapeutics
OVID
$98.8M
$2.49M 12.71%
7,531,996
XLO icon
3
Xilio Therapeutics
XLO
$42.5M
$1M 5.13%
1,475,121
AMWL icon
4
American Well
AMWL
$81.6M
$691K 3.53%
77,733
EQ icon
5
Equillium
EQ
$85.7M
$575K 2.94%
1,824,977
STTK icon
6
Shattuck Labs
STTK
$97.2M
$408K 2.09%
515,619
LYEL icon
7
Lyell Immunopharma
LYEL
$325M
$364K 1.86%
41,165
-1
TSBX
8
DELISTED
Turnstone Biologics
TSBX
$322K 1.64%
895,824
THRD
9
DELISTED
Third Harmonic Bio
THRD
$200K 1.02%
36,835
RANI icon
10
Rani Therapeutics
RANI
$229M
$104K 0.53%
203,190
LAB icon
11
Standard BioTools
LAB
$462M
$19.8K 0.1%
16,515